Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of atracurium administration methods and rocuronium for optimal intubation timing
IRCT20230518058225N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of atracurium and rocuronium in Need for endotracheal intubation (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Optimal time to intubation. Started Apr 2024; status: completed.
02
Drugs
atracuriumrocuronium
03
Conditions
Need for endotracheal intubation
Beyond the preview
Go deeper on IRCT20230518058225N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230518058225N2.